Group One Trading’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.02K | Buy |
2,863
+1,990
| +228% | +$6.27K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $2.74K | Sell |
873
-10,563
| -92% | -$33.2K | ﹤0.01% | 1639 |
|
|
2024
Q4 | $49.6K | Sell |
11,436
-30,158
| -73% | -$131K | ﹤0.01% | 1235 |
|
|
2024
Q3 | $111K | Buy |
41,594
+6,818
| +20% | +$18.2K | ﹤0.01% | 834 |
|
|
2024
Q2 | $77.2K | Buy |
34,776
+24,642
| +243% | +$54.7K | ﹤0.01% | 896 |
|
|
2024
Q1 | $54.1K | Sell |
10,134
-2,243
| -18% | -$12K | ﹤0.01% | 941 |
|
|
2023
Q4 | $18.3K | Sell |
12,377
-21,827
| -64% | -$32.3K | ﹤0.01% | 1286 |
|
|
2023
Q3 | $47.5K | Buy |
34,204
+6,228
| +22% | +$8.66K | ﹤0.01% | 1095 |
|
|
2023
Q2 | $41.1K | Buy |
27,976
+5,842
| +26% | +$8.59K | ﹤0.01% | 1055 |
|
|
2023
Q1 | $36.5K | Buy |
+22,134
| New | +$36.5K | ﹤0.01% | 1083 |
|
|
2022
Q4 | – | Sell |
-4,619
| Closed | -$7K | – | 2201 |
|
|
2022
Q3 | $7K | Sell |
4,619
-31,850
| -87% | -$48.3K | ﹤0.01% | 1644 |
|
|
2022
Q2 | $80K | Sell |
36,469
-7,085
| -16% | -$15.5K | ﹤0.01% | 1144 |
|
|
2022
Q1 | $108K | Buy |
43,554
+4,903
| +13% | +$12.2K | ﹤0.01% | 1209 |
|
|
2021
Q4 | $232K | Sell |
38,651
-33,668
| -47% | -$202K | ﹤0.01% | 1155 |
|
|
2021
Q3 | $482K | Buy |
72,319
+62,696
| +652% | +$418K | ﹤0.01% | 841 |
|
|
2021
Q2 | $64K | Buy |
+9,623
| New | +$64K | ﹤0.01% | 1454 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2049 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1849 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1718 |
|